rhamnosus GG (Keystone Postbiotic) This unique postbiotic combination increases butyrate, a short-chain fatty acid that directly stimulates GLP-1 receptors and helps extend feelings of fullness and improve metabolic control
When side effects do occur, they tend to be minor and include symptoms such as nausea, vomiting, gastrointestinal issues, and diarrhea
GLP-1 microdosing isnt about hitting dramatic weight loss goals or completely suppressing your appetite
Sources: Teichman et al., JCEM 2006 | Raun et al., Eur J Endocrinol 1998 | Alba et al., Am J Physiol 2006 Security Profile & Chemical Identity Molecular specifications of the two peptides and documented hormonal selectivity Chemical Identity Pre-formulated Mix Two complementary peptides targeting distinct receptors for synergistic GH stimulation Documented Hormonal Selectivity Profile verified in human clinical trials Key benefit of this combination Published Clinical Data Key studies on each component and the synergy of GHRH + GHRP 2-10x Dose-dependent increase in plasma GH (30-60 g/kg SC) Results CJC-1295 (days 28 and 49) Selective First GH secretagogue without raising cortisol, prolactin or ACTH levels Selectivity vs
D., Lipshultz, L
Finally, if you have physical limitations affecting your ability to handle semaglutide containers, discuss this with your pharmacist, who may recommend alternative formulations or adaptive devices to facilitate safe medication access